Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis
{{output}}
Background and objectives: The therapeutic strategy in patients with late-onset MS (LOMS) remains poorly defined. In this study, we aimed to evaluate both clinical and MRI outcomes between 2 cohorts of patients with relapsing-rem... ...
